Dynamic contrast-enhanced MRI of cervical cancers: Temporal percentile screening of contrast enhancement identifies parameters for prediction of chemoradioresistance

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 3, 2012, Pages

  Andersen, Erlend K F ^a   Hole, Knut Hkon ^a   Lund, Kjersti V ^a   Sundfør, Kolbein ^a   Kristensen, Gunnar B ^a   Lyng, Heidi ^a   Malinen, Eirik ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Cervical cancer; Contrast enhancement; Gd DTPA; MRI; Radiotherapy; Response prediction

Indexed keywords

CERVICAL CANCERS; CHEMORADIOTHERAPY; CONTRAST ENHANCEMENT; DCE-MRI; DYNAMIC CONTRAST ENHANCED MRI; DYNAMIC CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING; DYNAMIC SERIES; ETHICS COMMITTEE; GD-DTPA; LOCOREGIONAL CONTROL; LYMPH NODE; MULTI VARIATE ANALYSIS; NORMALIZED AREA; P-VALUES; PROGRESSION FREE SURVIVAL; RELATIVE RISKS; RESPONSE PREDICTION; SURVIVAL TESTS; TIME POINTS;

DISEASES; FORECASTING; GADOLINIUM; GRAPHIC METHODS; MULTIVARIANT ANALYSIS; RADIOTHERAPY; TUMORS;

MAGNETIC RESONANCE IMAGING;

CISPLATIN; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE;

ADENOSQUAMOUS CARCINOMA; ADULT; ADVANCED CANCER; AGED; ARTICLE; BRACHYTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; COHORT ANALYSIS; CONTRAST ENHANCEMENT; DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; NORMALIZED AREA UNDER THE CURVE; NORMALIZED RELATIVE SIGNAL INCREASE; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOLOGICAL PARAMETERS; PREDICTION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; RADIOLOGICAL PARAMETERS; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CONTRAST MEDIA; DISEASE-FREE SURVIVAL; DRUG RESISTANCE, NEOPLASM; FEMALE; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RADIATION TOLERANCE; TUMOR BURDEN; UTERINE CERVICAL NEOPLASMS;

EID: 84856400030     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.05.050     Document Type: Article

References (18)

1. S.A. Cannistra, and J.M. Niloff Cancer of the uterine cervix N Engl J Med 334 1996 1030 1038
2. V.N. Harry, F.J. Gilbert, and D.E. Parkin Predicting the response of advanced cervical and ovarian tumors to therapy Obstet Gynecol Surv 64 2009 548 560
3. V.N. Harry, H. Deans, E. Ramage, D.E. Parkin, and F.J. Gilbert Magnetic resonance imaging in gynecological oncology Int J Gynecol Cancer 19 2009 186 193
4. M.A. Zahra, K.G. Hollingsworth, E. Sala, D.J. Lomas, and L.T. Tan Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy Lancet Oncol 8 2007 63 74
5. J.L. Evelhoch Key factors in the acquisition of contrast kinetic data for oncology J Magn Reson Imaging 10 1999 254 259
6. A. Fyles, M. Milosevic, and D. Hedley Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer J Clin Oncol 20 2002 680 687
7. M. Milosevic, A. Fyles, and D. Hedley Interstitial fluid pressure predicts survival in patients with cervix cancer independent of clinical prognostic factors and tumor oxygen measurements Cancer Res 61 2001 6400 6405
8. K. Sundfor, H. Lyng, C.G. Trope, and E.K. Rofstad Treatment outcome in advanced squamous cell carcinoma of the uterine cervix: Relationships to pretreatment tumor oxygenation and vascularization Radiother Oncol 54 2000 101 107
9. R.A. Cooper, B.M. Carrington, and J.A. Loncaster Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix Radiother Oncol 57 2000 53 59
10. M.A. Haider, I. Sitartchouk, and T.P. Roberts Correlations between dynamic contrast-enhanced magnetic resonance imaging-derived measures of tumor microvasculature and interstitial fluid pressure in patients with cervical cancer J Magn Reson Imaging 25 2007 153 159
11. H. Lyng, A.O. Vorren, and K. Sundfor Assessment of tumor oxygenation in human cervical carcinoma by use of dynamic Gd-DTPA-enhanced MR imaging J Magn Reson Imaging 14 2001 750 756
12. J.L. Evelhoch, P.M. LoRusso, and Z. He Magnetic resonance imaging measurements of the response of murine and human tumors to the vascular-targeting agent ZD6126 Clin Cancer Res 10 2004 3650 3657
13. S.B. Donaldson, D.L. Buckley, and J.P. O'Connor Enhancing fraction measured using dynamic contrast-enhanced MRI predicts disease-free survival in patients with carcinoma of the cervix Br J Cancer 102 2010 23 26
14. H. Hawighorst, P.G. Knapstein, and M.V. Knopp Uterine cervical carcinoma: Comparison of standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival Cancer Res 58 1998 3598 3602
15. N.A. Mayr, W.T. Yuh, and J.C. Arnholt Pixel analysis of MR perfusion imaging in predicting radiation therapy outcome in cervical cancer J Magn Reson Imaging 12 2000 1027 1033
16. M.A. Zahra, L.T. Tan, and A.N. Priest Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer Int J Radiat Oncol Biol Phys 74 2009 766 773
17. N.A. Mayr, W.T. Yuh, and D. Jajoura Ultra-early predictive assay for treatment failure using functional magnetic resonance imaging and clinical prognostic parameters in cervical cancer Cancer 116 2010 903 912
18. N.A. Mayr, J.Z. Wang, and D. Zhang Longitudinal changes in tumor perfusion pattern during the radiation therapy course and its clinical impact in cervical cancer Int J Radiat Oncol Biol Phys 77 2010 502 508